SCHEMBL5524845

SCHEMBL5524845

COC(=O)c1cc(-c2ccc(OCc3ccccc3)cn2)n(-c2ccc(Cl)nn2)n1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MDM2 Q00987 2/20 0.43
MCL1 Q07820 2/20 0.42
BCL2 P10415 1/20 0.42
P4HTM Q9NXG6 1/20 0.41
NOTUM Q6P988 1/20 0.41
NPC1 O15118 2/20 0.38
RAB9A P51151 2/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
ALKBH1 Q13686 4/20 0.37
FAAH O00519 3/20 0.36
MGLL Q99685 1/20 0.36
CYP4F2 P78329 2/20 0.35
CYP4A11 Q02928 2/20 0.35
LMNA P02545 1/20 0.35
HPGD P15428 1/20 0.35
ALOX5 P09917 1/20 0.35
ALDH1A1 P00352 1/20 0.35
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
RPA1 P27694 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5521981 0.90 MDM2 (0.43) MDM2MCL1BCL2P4HTMNOTUM
SCHEMBL5527972 0.84 ALOX5 (0.37) NPC1RAB9ASMN1; SMN2ALOX5ALDH1A1
SCHEMBL5526855 0.83 MDM2 (0.52) MDM2MCL1BCL2P4HTMALKBH1
SCHEMBL5522528 0.82 ALOX5 (0.40) RAB9ASMN1; SMN2FAAHMGLLHPGD
SCHEMBL2917351 0.81 SLC16A3 (0.40) RAB9ASMN1; SMN2FAAHMGLLALDH1A1
SCHEMBL5266014 0.79 EGLN2 (0.39) SMN1; SMN2ALOX5MEN1KMT2ARPA1
SCHEMBL5526239 0.78 MDM2 (0.41) MDM2MCL1BCL2P4HTMALKBH1
SCHEMBL5269426 0.78 SMN1; SMN2 (0.38) RAB9ASMN1; SMN2FAAHMGLLHPGD
SCHEMBL5527916 0.76 ALDH1A1 (0.50) MDM2MCL1BCL2P4HTMNPC1
SCHEMBL5266028 0.76 RAB9A (0.39) NPC1RAB9ASMN1; SMN2HPGDALOX5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070219210-A1 Amidopyrazole Derivative DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2007-09-20 US disclosed
CN-1902191-A Amidopyrazole derivative DAIICHI SEIYAKU CO (JP) 2007-01-24 CN disclosed
EP-1698626-A1 AMIDOPYRAZOLE DERIVATIVE DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2006-09-06 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070219210-A1 Amidopyrazole Derivative PTGER1, PTGS1, PTGER2 MDM2 4288/4885MCL1 1451/4885BCL2 3148/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.